You are here

Home » Content

Diabetik retinopatide Farnsworth-Munsell 100 ton renk testi sonuçları

The results of Farnsworth-Munsell (FM) 100 hue test in diabetic retinopathy

Journal Name:

  • Selçuk Tıp Dergisi

Publication Year:

  • 2006

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
Aim: The late complications of diabetes mellitus (DM] threaten the eye and cause blindness. Therefore the early diagnosis has significant importance. Our aim is to evaluate the value of Farnsworth-Munsell (FM) 100 hue test which is used for retinopathy diagnosis in DM patients. Material and method: FM 100 hue test was performed on, 186 eyes of 100 DM patients which were admitted to Ophthalmology Outpatient Department of Meram Medical Faculty, Selçuk University and Turkish Diabetes Society outpatient department. For the control group 60 eyes of 30 healthy subjects were tested. The results were evaluated by quadrant analysis method. X2 test was used as statistical method and P < 0.05 was accepted as significant. Results: When results were compared, there was a significant difference for the degree of the deterioration of the color vision in DM patients which was correlated with the progression and the duration of the disease. The dominant colour vision defect was blue-yellow type. Conclusion: It was concluded that, functional loss occurs before diabetic retinopathy lesions occur and FM 100 hue test is a valuable method for early diagnosis.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Diabetes mellitus (DM), geç komplikasyonları nedeniyle görmeyi tehdit eder ve hatta görme kayıplarına yol açar. Bu nedenle de fonksiyonel değişikliklerin erken tanısı önem kazanmaktadır. Çalışmamızın amacı DM'lu olgularda retinal hasarın erken dönemde tespiti ve hastalığın seyrini izlemede kullanılan testlerden biri olan Farnsworth-Munsell (FM) 100 ton renk görme testinin tanısal değerinin araştırılmasıdır. Gereç ve Yöntem." S. Ü. Meram Tıp Fakültesi Göz Hastalıkları Anabiiim Dalı polikliniği ve Türk Diabet Cemiyeti polikliniğine başvurarak takip ve tedavi edilen 100 hastanın 186 gözüne ve kontrol grubu olarak belirlediğimiz 30 sağlıklı bireyin 60 gözüne FM 100 ton testi uygulandı. FM 100 ton testi sonuçlarının değerlendirilmesinde kadran analizi yöntemi kullanıldı. Sonuçların istatistiksel açıdan değerlendirilmesinde X2 testi kullanıldı, P<0.05 anlamlı olarak kabul edil¬di. Bulgular: DM'lu grup İle kontrol grubu karşılaştırıldığında, DM'lu hastalarda renk görmede belirgin kötüleşmenin olduğu ve bu renk görme defektlerinin hastalığın ilerlemesi ve süresi ile doğru orantılı olarak arttığı, hakim olan renk defektinin mavi-sarı renk defekti tipinde olduğu gözlendi. Sonuç: DM'lu olgularda henüz retinopati bulguları ortaya çıkmadan renkli görmede bozukluk oluştuğu, bu defektin tespitinde FM 100 ton tes¬tinin öneminin olduğu, retinopatinin tanı ve takibinde bu testin kullanılmasının hastalığın erken tanısında önem¬li ölçüde yardımcı olabileceği sonucuna varıldı.
FULL TEXT (PDF): 
PDF icon arastirmax-diabetik-retinopatide-farnsworth-munsell-100-ton-renk-testi-sonuclari.pdf
  • 1
9-16
  • Turkish

REFERENCES

References: 

1. Pocorny J, Smith CV. Color vision and night vision in "Retina" Eds by, Stephan JR. New York: Mosby; 1989; I 09T26.
2. Daw NW Color vision in "Adler's Physiology of the eye" Eds By Hart WM, New York: Mosby; 1995; 545-61.
3. Hart MW. Acquired dyschromatopsias. Surv Ophthalmol 1987;32:10-3!.
4. Klein EK, Klein R, Moss SE. The Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology I 994; 7-16.
5. Erdoğan E. Diabetes meilitusun tedavisi, Ed. Erdoğan E, Bilimsel Tıp Yayınevi; İstanbul; 1997; 5-13.
6. Yusuf O. Diabetes Mellitus, "Endokrinoloji, Metabolizma ve Beslenme Hastalıkları", Editor Ergin Sencer, Nobel Tıp Kitabevi: Ankara; 2001, 250-86.
7. Klein R, Klein BEK, Moss SE. Prevalance and risk of dia-betic retinopathy when age at diagnosis is 30 or more years. The Wisconsin Epidemiologic Study of Diabetic Retinopathy No III. Arch Ophthalmol 1984; 102:527-32.
8. Kurtenbach A, Erb C, Adler M, Born B. Colour vision in diabetics tested by the Fansworth-Munsell 28-hue desa-turated test. Colour Research and Application 2001; 26:292-6
9. Gündüz K, Arden GB, Perry S, Weinstein GW. Hitchings RA. Color vision defects in ocular hypertension and glau¬coma. Quantification with a computer-driven color tele¬vision system. Arch Ophthalmol 1988; 106.929-35
10. Gündüz K, Arden GB. Changes in colour contrast sensi-tivity associated with operating argon lasers. Br J Ophthalmol 1989; 73:241-6.
1 1. Smith CV, Pocorny J. Pass AS. Colour axis determination
on the Farnsworth Munsell 100-hue test. Am J
Ophthalmol 1985; 100:176-82.
12. Bayraktar MZ Diabetik retinopati epidemiyolojisi, Diabetik
Retinopati" editör Şehirbay Ö, İstanbul: Nobel Kitabevi
2000; 1-9.
13. Tregear SJ, Knowles PJ, Ripley LG, Casswell AG. Chromatic-Contrast threshold impairment in diabetes. Eye 1997; I 1:53-546
14. Kinnear PR. Aspinall PA, Lakowski R. The diabetic eye and colour vision. Trans Ophthalmol Soc U K 1972; 92:69-78.
15. Lakowski R. The Pickford - Nicolson anomaloscope as a test for acquired dyschromatopsias. Mod Probl Ophthalmol 1972; I 1:25-33.
1 6. Condit R, Bresnick G, Korth K. Hue discrimination loss and retinopathy severity in diabetes mellitus. Invest Ophthalmol Vis Sci 1982; 22:52-5.
1 7. Arden GB, Gündüz K. Perry S. Color vision testing with a
computer graphics system. Clin Vis Sci 1 988; 2.303-20.
18. Dosso AA, Bonvin ER. Morel Y, Golay A, Assai JP, Leuenburger PM. Risk factors associated with colour vision defects in diabetic patients. Graefe's Arch Clin Exp Ophthalmol 1996; 234:300-5.
19. Wolbrecht VJ. Schneck ME, Adams AJ. Linfoot JA. Diabetic short-wavelenght sensitivity variations with induced changes in blood glucose level. Invest Ophthalmol Vis Sci 1994; 35: 1243-6.
20. Ewans DW, Harris A, Danis RP, Arend O. Martin B. Altered retrobulbar vasicular reactivity in early diabetic retinopathy. BJ Ophthalmol 1997; 81: 279-82.
2 1. Berninger TA. Canning C, Strong N. Gündüz K, Arden
GB. Color vision disturbance in laser operators and patients: Comparison of argon and dye lasers. Klin Monatsbl Augenheilkd 1990; 197: 494-507.
22. Apostol S. Carstocea B. Color vision in diabetics. Ophthalmologia 1994; 38: 17-22.
23. Fong DS, Barton FB, Bresnick GH. Impaired color vision associated with diabetic retinopathy. Am J Ophthalmol 1999; 5: 612-7.
24. Gillow J J. Gray M. The national screening committee review of diabetic retinopathy screening. Eye 2001; 15: 1-2.
25. Arden GB, Wolf JE, Tsang Y Does dark adaptation exac¬erbate diabetic retinopathy? Evidence and a linking hypothesis. Vision Research 1998; 38: 1723-9.
26. Ghirland G, Di Leo M, Caputo S, Cercone S, Greco A. From functional to microvascular abnormalities in early diabetic retinopathy. Diabetes/Metabolism Reviews 1997, 13.15-35.
27. Parisi V, Uccioli L. Visual electrophysical responses in per¬sons with type ! diabetes. Diabetes / Metabolism Research and Reviews 2001; 17:1 2-8.
28. Birch J, Dain SJ, An averaging method for the interpreta-tion of the Farnsworth - Munsell 100-hue test-ll. Colour vision defects acquired in diabetic retinopathy. Ophthal Physiol Opt 1987; 3: 281-91.
29. Green FD, Ghafour IM, Allan D. Color vision of diabetics. Br J Ophthalmol 1 985; 69: 533-6.
30. Roy MS, Macculoch C, Hanna AK. Mortimer C. Colour vision In long-standing diabetes mellitus, ßr J Ophthalmol 1984; 68: 215-7.
31. Hardy KJ, Upton J, Scase MO, Foster DH, Scarpello JHB. Detection of colour vision abnormalities in uncomplicat-ed type 1 diabetic patients with angiographically normal retinas. BrJ Ophtatmol 1995; 76: 461-4.
32. Bekir N, Karaaslan C. Diabetik retlnopatinin erken tanismda FM 100-ton testinin yeri ve önemi. T Klin Oftalmol 1993; 23: 161-5.
33. Bresnick GH, Condid SR, Palta M. Association of hue dis-crimination loss and diabetic retinopathy. Arch Ophthalmol 1985; 103: 1317-27.
34. Fontana M, Verriest G. Modification by floangiography of color vision in diabetic patients. Ophthalmologica 1986; 192:210-6.
35. Utku D, Atmaca LS. Farnsworth-Munsell 100-hue test for patients with diabetes mellitus. Ann Ophthalmol 1992 Jun;24|6):205-8.
36. Mantyjarvi M. Screening of diabetics who read incorrect¬ly colour- dependent glucose test strips. Doc Ophthalmol 1992, 80: 323-8.
37. Peduzzi M. Longanesi f_ Ascari A, Cascione S, Galletti M. Screening of early color vision loss in diabetic patients. Fr J Ophthalmol 1989; 12:791-6.

38. Palmberg I. Smith M. Waltman S. The natural history of retinopathy in diabetic patients. Ophthalmology ¡981, 88; 613-8.
39. Klein R, Klein BEK, Moss SE. Davis MD, Demets DL. Retinopathy in young - onset diabetic patients. Diabetes Care 1985; 8: 311-5.
40. Aspinal PA Kinnear PR. Duncan U. Prediction of diabetic retinopathy from clinical variables and color vision data. Diabetes Care 1983; 6:144-8.
41. Moloney J, Drury MI. Retinopathy and retinal function in insulin-dependent diabetes mellitus. Br J Ophthalmol 1982; 62:759-61.
42. Hansen OB, Bangstad HJ, Hultgren S, Fletcher R. Jorgensen KD. Psychophysical visual function, retinopa-thy and glycemic control in insulin- dependent diabetics with normal visual acuity. Acta Opthalmol 1993; 7 1: 230¬57.
43. KurtenbachA, Schiefer U. NeuA, Zrenner E. Preretinopic changes in the colour vision of juvenile diabetics. Br J Ophthalmol 1999; 83: 43-6.
44. Trick GL, Burde RM. Gordon MO. The relationship between hue discrimination and contrast sensitivity in patients with diabetes mellitus. Ophthalmology 1988. 95: 693-8.
45. Roy MS, Diabetic retinopathy in African Americans with type 1 diabetes. Arch Ophthalmol 2000; 118: 105-15.
46. DCCT Research Group The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin dependent diabetes. N Eng J Med 1993; 329; 977-86.
47. Bouquet C, Gardette B, Gortan C, Therme P. Abraini JH. Color discrimination under chronic hypoxic conditions. Percept Mot Skills 2000 Feb; 90[ I); 169-79.
48. Holopigian K, Greenstein VC, Seile W. Evidence for pho-toreceptor changes in patients with diabetic retinopathy, Invest Ophthalmol Vis Sci 1997; 39.235-65.
49. Dean MF, Arden GB, Dornhost A. Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects. Br J Ophthalmol 1997; 81: 27-30.

Thank you for copying data from http://www.arastirmax.com